Aptadir Therapeutics
Milan · Founded 2024
About Aptadir Therapeutics
Aptadir Therapeutics is developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions.
Company Facts
- Founded: 2024
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2024)
- Website: https://aptadir.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/aptadir-therapeutics-79900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.